Physician profile
Michael Megaly
NPI 1083029755
$44,716.28
in general payments reported to CMS, 2019-2025
39 companies · $6,616 in 2025
The $6,616 reported for 2025 was more than what 93% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $2,049 · 2021: $27K · 2022: $1,891 · 2023: $3,525 · 2024: $3,445 · 2025: $6,616.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,193 · Travel and Lodging: $5,104 · Consulting Fee: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,192.51 |
| Travel and Lodging | $5,103.93 |
| Consulting Fee | $290.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $26,224.01 | 2020-2025 | Mamba, General - Therapies, General - Vascular Access |
| Penumbra, INC. | $3,904.19 | 2022-2025 | Indigo System, Penumbra System |
| Abiomed | $3,230.69 | 2021-2025 | Impella |
| Medtronic, INC. | $2,529.50 | 2022-2025 | Turbohawk, Venaseal, Hawkone |
| Medtronic Vascular, INC. | $1,916.71 | 2019-2020 | |
| Asahi Intecc USA, INC. | $1,393.69 | 2020-2025 | Asahi Peripheral Vascular Wires, Asahi Coronary Wires, Peripheral Vascular |
| Abbott Laboratories | $1,028.05 | 2020-2025 | Esprit, Jeti Peripheral Catheter, Hi-Torque Command |
| Inari Medical, INC. | $731.37 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shockwave Medical, INC | $438.05 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Teleflex LLC | $388.87 | 2021-2025 | Turnpike, Manta, Orsiro Mission |
| W. L. Gore & Associates, INC. | $327.80 | 2024-2025 | Product In Development, Gore Viabahn Endoprosthesis |
| Agepha Pharma Fz LLC | $310.86 | 2025 | Lodoco |
| Acist Medical Systems, INC. | $267.00 | 2021 | |
| Pfizer INC. | $229.90 | 2022-2023 | |
| Cardiovascular Systems INC. | $196.39 | 2021-2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $194.27 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $152.26 | 2022-2023 | Farxiga |
| Chiesi USA, INC. | $124.61 | 2024 | Kengreal |
| Inquis Medical, INC. | $115.47 | 2024 | |
| Bard Peripheral Vascular, INC. | $98.51 | 2022 | |
| Irhythm Technologies, INC. | $97.43 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Cardinal Health 200 LLC | $91.80 | 2019 | |
| Stryker Corporation | $90.55 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Terumo Medical Corporation | $87.63 | 2024 | Navicross |
| Merck Sharp & Dohme LLC | $83.12 | 2022-2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $75.78 | 2022-2023 | Lifevest |
| Itamar Medical INC | $56.15 | 2022-2023 | Watchpatone |
| Edwards Lifesciences Corporation | $55.13 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.08 | 2022-2023 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $41.87 | 2022-2023 | |
| Philips North America LLC | $38.42 | 2022 | |
| Biotronik INC. | $33.35 | 2025 | Orsiro Mission |
| Amgen INC. | $25.09 | 2023 | Repatha |
| Verge Medical, INC. | $22.29 | 2021 | |
| Jazz Pharmaceuticals INC. | $18.93 | 2020 | |
| Zoll Circulation INC | $17.94 | 2023 | Therox Ds2 Console, Catheter, Downstream Cartridge |
| Reflow Medical INC | $17.27 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $16.25 | 2023 | Camzyos |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Megaly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.